Loading...

Judith Silverstein Currier

Title(s)Professor, Medicine
SchoolMedicine
Address760 Westwood Plaza 32-144
Los Angeles CA 90024
Phone56689
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    UCLA AIDS Prevention and Treatment Clinical Trials Unit
    NIH/NIAID UM1AI069424Jun 3, 2020 - Nov 30, 2020
    Role: Principal Investigator
    Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/
    NIH/NIAID UM1AI068636May 18, 2020 - Nov 30, 2020
    Role: Principal Investigator
    Prospective Evaluation of Antiviral Therapy and Cardiac Health
    NIH/NHLBI R01HL095132Sep 25, 2008 - Jun 30, 2014
    Role: Principal Investigator
    Postdoctoral Training in Global AIDS Prevention Research
    NIH/NIMH T32MH080634Jul 4, 2007 - Jun 30, 2022
    Role: Principal Investigator
    UCLA AIDS Prevention and Treatment Clinical Trials Unit
    NIH/NIAID U01AI069424Feb 1, 2007 - Nov 30, 2013
    Role: Principal Investigator
    Optimizing Antiretroviral Therapy in HIV
    NIH/NIAID K24AI056933Aug 1, 2003 - Feb 28, 2014
    Role: Principal Investigator
    STD FACULTY EXPANSION PROGRAM
    CDC/NCHHSTP R30PS921114Mar 1, 2002 - Feb 28, 2007
    Role: Principal Investigator
    AIDS CLINICAL TRIALS UNIT
    NIH/NIAID U01AI027660Jun 30, 1986 - Jun 30, 1991
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial. J Infect Dis. 2020 Jul 09; 222(Supplement_1):S63-S69. Neilan TG, Nguyen KL, Zaha VG, Chew KW, Morrison L, Ntusi NAB, Toribio M, Awadalla M, Drobni ZD, Nelson MD, Burdo TH, Van Schalkwyk M, Sax PE, Skiest DJ, Tashima K, Landovitz RJ, Daar E, Wurcel AG, Robbins GK, Bolan RK, Fitch KV, Currier JS, Bloomfield GS, Desvigne-Nickens P, Douglas PS, Hoffmann U, Grinspoon SK, Ribaudo H, Dawson R, Goetz MB, Jain MK, Warner A, Szczepaniak LS, Zanni MV. PMID: 32645158.
      View in: PubMed   Mentions:    Fields:    
    2. Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial. J Infect Dis. 2020 Jul 09; 222(Supplement_1):S20-S30. Zanni MV, Currier JS, Kantor A, Smeaton L, Rivard C, Taron J, Burdo TH, Badal-Faesen S, Lalloo UG, Pinto JA, Samaneka W, Valencia J, Klingman K, Allston-Smith B, Cooper-Arnold K, Desvigne-Nickens P, Lu MT, Fitch KV, Hoffman U, Grinspoon SK, Douglas PS, Looby SE. PMID: 32645159.
      View in: PubMed   Mentions:    Fields:    
    3. Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial. J Infect Dis. 2020 Jul 09; 222(Supplement_1):S8-S19. Fichtenbaum CJ, Ribaudo HJ, Leon-Cruz J, Overton ET, Zanni MV, Malvestutto CD, Aberg JA, Kileel EM, Fitch KV, Van Schalkwyk M, Kumarasamy N, Martinez E, Santos BR, Joseph Y, Lo J, Siminski S, Melbourne K, Sponseller CA, Desvigne-Nickens P, Bloomfield GS, Currier JS, Hoffmann U, Douglas PS, Grinspoon SK. PMID: 32645162.
      View in: PubMed   Mentions:    Fields:    
    4. Erratum to: Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir. J Infect Dis. 2020 Jun 11; 221(12):2083-2084. Brown TT, Moser C, Currier JS, Ribaudo HJ, Rothenberg J, Kelesidis T, Yang O, Dubé MP, Murphy RL, Stein JH, McComsey GA. PMID: 32022230.
      View in: PubMed   Mentions:    Fields:    
    5. Immune Biomarkers in the Prediction of Future Myocardial Infarctions in People With Human Immunodeficiency Virus. Clin Infect Dis. 2020 Apr 10; 70(8):1764-1767. Trevillyan JM, Moser C, Currier JS, Sallam T. PMID: 31414117.
      View in: PubMed   Mentions:    Fields:    
    6. Hepatotoxicity and Liver-Related Mortality in Women of Child-Bearing Potential Living With HIV and High CD4 Counts Initiating Efavirenz-Containing Regimens. Clin Infect Dis. 2020 Mar 12. Bhattacharya D, Gupta A, Tierney C, Huang S, Peters MG, Chipato T, Martinson F, Mohtashemi N, Dula D, George K, Chaktoura N, Klingman K, Gnanashanmugam D, Currier JS, Fowler MG. PMID: 32161944.
      View in: PubMed   Mentions:    Fields:    
    7. Monthly Injectable Antiretroviral Therapy - Version 1.0 of a New Treatment Approach. N Engl J Med. 2020 03 19; 382(12):1164-1165. Currier JS. PMID: 32130808.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    8. Antiretroviral therapy initiation is associated with decreased visceral and subcutaneous adipose tissue density in people living with HIV. Clin Infect Dis. 2020 Feb 28. Debroy P, Lake JE, Moser C, Olefsky M, Erlandson KM, Scherzinger A, Stein JH, Currier JS, Brown TT, McComsey GA. PMID: 32107532.
      View in: PubMed   Mentions:    Fields:    
    9. Reducing cardiovascular risk among people living with HIV: Rationale and design of the INcreasing Statin Prescribing in HIV Behavioral Economics REsearch (INSPIRE) randomized controlled trial. Prog Cardiovasc Dis. 2020 Mar - Apr; 63(2):109-117. Takada S, Ober AJ, Currier JS, Goldstein NJ, Horwich TB, Mittman BS, Shu SB, Tseng CH, Vijayan T, Wali S, Cunningham WE, Ladapo JA. PMID: 32084445.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    10. Comparison of guidelines for HIV viral load monitoring among pregnant and breastfeeding women in sub-Saharan Africa. AIDS. 2020 02 01; 34(2):311-315. Lesosky M, Raboud JM, Glass T, Brummel SS, Ciaranello AL, Currier JS, Essajee S, Havlir DV, Koss CA, Ogwu A, Shapiro RL, Abrams EJ, Myer L. PMID: 31634186.
      View in: PubMed   Mentions: 1     Fields:    
    11. The impact of short term Antiretroviral Therapy (ART) interruptions on longer term maternal health outcomes-A randomized clinical trial. PLoS One. 2020; 15(1):e0228003. Atuhaire P, S Brummel S, Mmbaga BT, Angelidou K, Fairlie L, Violari A, Theron G, Mukuzunga C, Mawlana S, Mubiana-Mbewe M, Naidoo M, Makanani B, Mandima P, Nematadzira T, Suryavanshi N, Mbengeranwa T, Loftis A, Basar M, McCarthy K, Currier JS, Fowler MG. PMID: 31999753.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Cabotegravir Is Not Associated With Weight Gain in Human Immunodeficiency Virus-uninfected Individuals in HPTN 077. Clin Infect Dis. 2020 Jan 02; 70(2):319-322. Landovitz RJ, Zangeneh SZ, Chau G, Grinsztejn B, Eron JJ, Dawood H, Magnus M, Liu AY, Panchia R, Hosseinipour MC, Kofron R, Margolis DA, Rinehart A, Adeyeye A, Burns D, McCauley M, Cohen MS, Currier JS. PMID: 31125395.
      View in: PubMed   Mentions: 2     Fields:    
    13. Predictors of Viremia in Postpartum Women on Antiretroviral Therapy. J Acquir Immune Defic Syndr. 2020 01 01; 83(1):72-80. Hoffman RM, Warshaw MG, Amico KR, Pilotto J, Masheto G, Achalapong J, Machado E, Chokephaibulkit K, Duarte G, João E, Graham KK, Knapp KM, Stek AM, Scott GB, Coletti A, Loftis AJ, Chakhtoura N, Currier JS. PMID: 31651545.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Time to viral rebound and safety after antiretroviral treatment interruption in postpartum women compared with men. AIDS. 2019 11 15; 33(14):2149-2156. Le CN, Britto P, Brummel SS, Hoffman RM, Li JZ, Flynn PM, Taha TE, Coletti A, Fowler MG, Bosch RJ, Gandhi RT, Klingman KL, McIntyre JA, Currier JS. PMID: 31373919.
      View in: PubMed   Mentions:    Fields:    
    15. Linked dual-class HIV resistance mutations are associated with treatment failure. JCI Insight. 2019 10 03; 4(19). Boltz VF, Shao W, Bale MJ, Halvas EK, Luke B, McIntyre JA, Schooley RT, Lockman S, Currier JS, Sawe F, Hogg E, Hughes MD, Kearney MF, Coffin JM, Mellors JW. PMID: 31487271.
      View in: PubMed   Mentions:    Fields:    
    16. Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding women. AIDS. 2019 08 01; 33(10):1657-1662. Murnane PM, Bacchetti P, Currier JS, Brummel S, Okochi H, Phung N, Louie A, Kuncze K, Hoffman RM, Nematadzira T, Soko DK, Owor M, Saidi F, Flynn PM, Fowler MG, Gandhi M. PMID: 31021852.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Safety and Impact of Low-dose Methotrexate on Endothelial Function and Inflammation in Individuals With Treated Human Immunodeficiency Virus: AIDS Clinical Trials Group Study A5314. Clin Infect Dis. 2019 05 17; 68(11):1877-1886. Hsue PY, Ribaudo HJ, Deeks SG, Bell T, Ridker PM, Fichtenbaum C, Daar ES, Havlir D, Yeh E, Tawakol A, Lederman M, Currier JS, Stein JH. PMID: 30219823.
      View in: PubMed   Mentions: 4     Fields:    
    18. Lower Pretreatment Gut Integrity Is Independently Associated With Fat Gain on Antiretroviral Therapy. Clin Infect Dis. 2019 04 08; 68(8):1394-1401. El Kamari V, Moser C, Hileman CO, Currier JS, Brown TT, Johnston L, Hunt PW, McComsey GA. PMID: 30137242.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    19. CROI 2019: complications and coinfections in HIV infection. Top Antivir Med. 2019 Apr; 27(1):34-40. Currier JS, Havlir DV. PMID: 31137001.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Antiretroviral Concentrations in Hair Strongly Predict Virologic Response in a Large Human Immunodeficiency Virus Treatment-naive Clinical Trial. Clin Infect Dis. 2019 03 05; 68(6):1044-1047. Gandhi M, Bacchetti P, Ofokotun I, Jin C, Ribaudo HJ, Haas DW, Sheth AN, Horng H, Phung N, Kuncze K, Okochi H, Landovitz RJ, Lennox J, Currier JS. PMID: 30184104.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    21. Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE). Am Heart J. 2019 06; 212:23-35. Grinspoon SK, Fitch KV, Overton ET, Fichtenbaum CJ, Zanni MV, Aberg JA, Malvestutto C, Lu MT, Currier JS, Sponseller CA, Waclawiw M, Alston-Smith B, Cooper-Arnold K, Klingman KL, Desvigne-Nickens P, Hoffmann U, Ribaudo HJ, Douglas PS. PMID: 30928825.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    22. Outcomes of a Career Development Program for Underrepresented Minority Investigators in the AIDS Clinical Trials Group. Open Forum Infect Dis. 2019 Mar; 6(3):ofz069. Velásquez GE, Huaman MA, Powell KR, Cohn SE, Swaminathan S, Outlaw M, Schulte G, McNeil Q, Currier JS, Del Rio C, Castillo-Mancilla J. PMID: 30895207.
      View in: PubMed   Mentions:
    23. Adverse Pregnancy Outcomes Among Women Who Conceive on Antiretroviral Therapy. Clin Infect Dis. 2019 01 07; 68(2):273-279. Hoffman RM, Brummel SS, Britto P, Pilotto JH, Masheto G, Aurpibul L, Joao E, Purswani MU, Buschur S, Pierre MF, Coletti A, Chakhtoura N, Klingman KL, Currier JS. PMID: 29868833.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Maternal health outcomes among HIV-infected breastfeeding women with high CD4 counts: results of a treatment strategy trial. HIV Clin Trials. 2018 12; 19(6):209-224. Hoffman RM, Angelidou KN, Brummel SS, Saidi F, Violari A, Dula D, Mave V, Fairlie L, Theron G, Kamateeka M, Chipato T, Chi BH, Stranix-Chibanda L, Nematadzira T, Moodley D, Bhattacharya D, Gupta A, Coletti A, McIntyre JA, Klingman KL, Chakhtoura N, Shapiro DE, Fowler MG, Currier JS. PMID: 30890061.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    25. Brachial Artery Echogenicity and Grayscale Texture Changes in HIV-Infected Individuals Receiving Low-Dose Methotrexate. Arterioscler Thromb Vasc Biol. 2018 12; 38(12):2870-2878. Stein JH, Yeh E, Weber JM, Korcarz C, Ridker PM, Tawakol A, Hsue PY, Currier JS, Ribaudo H, Mitchell CKC. PMID: 30571173.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    26. Changes in Waist Circumference in HIV-Infected Individuals Initiating a Raltegravir or Protease Inhibitor Regimen: Effects of Sex and Race. Open Forum Infect Dis. 2018 Nov; 5(11):ofy201. Bhagwat P, Ofotokun I, McComsey GA, Brown TT, Moser C, Sugar CA, Currier JS. PMID: 30465010.
      View in: PubMed   Mentions:
    27. Pregnancy outcomes among HIV-infected women who conceived on antiretroviral therapy. PLoS One. 2018; 13(7):e0199555. Stringer EM, Kendall MA, Lockman S, Campbell TB, Nielsen-Saines K, Sawe F, Cu-Uvin S, Wu X, Currier JS. PMID: 30020964.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    28. Brief Report: Changes in Plasma RANKL-Osteoprotegerin in a Prospective, Randomized Clinical Trial of Initial Antiviral Therapy: A5260s. J Acquir Immune Defic Syndr. 2018 07 01; 78(3):362-366. Kelesidis T, Moser CB, Johnston E, Stein JH, Dube MP, Yang OO, McComsey GA, Currier JS, Brown TT. PMID: 29533303.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. What Is the Best Model for HIV Primary Care? Assessing the Influence of Provider Type on Outcomes of Chronic Comorbidities in HIV Infection. J Infect Dis. 2018 06 20; 218(2):337-339. Morales Rodriguez K, Khalili J, Trevillyan J, Currier J. PMID: 29481635.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    30. Soluble levels of receptor for advanced glycation endproducts and dysfunctional high-density lipoprotein in persons infected with human immunodeficiency virus: ACTG NWCS332. Medicine (Baltimore). 2018 Jun; 97(22):e10955. Kelesidis T, Kendall MA, Danoff A, Aberg JA, Currier JS, Schmidt AM. PMID: 29851842.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    31. Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy. PLoS One. 2018; 13(5):e0196395. Offor O, Utay N, Reynoso D, Somasunderam A, Currier J, Lake J. PMID: 29746485.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. Telmisartan Therapy Does Not Improve Lymph Node or Adipose Tissue Fibrosis More Than Continued Antiretroviral Therapy Alone. J Infect Dis. 2018 05 05; 217(11):1770-1781. Utay NS, Kitch DW, Yeh E, Fichtenbaum CJ, Lederman MM, Estes JD, Deleage C, Magyar C, Nelson SD, Klingman KL, Bastow B, Luque AE, McComsey GA, Douek DC, Currier JS, Lake JE. PMID: 29401318.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    33. CROI 2018: Complications of HIV Infection and Antiretroviral Therapy. Top Antivir Med. 2018 May; 26(1):22-29. Currier JS, Havlir DV. PMID: 29727294.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    34. Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine. N Engl J Med. 2018 04 26; 378(17):1593-1603. Rough K, Seage GR, Williams PL, Hernandez-Diaz S, Huo Y, Chadwick EG, Currier JS, Hoffman RM, Barr E, Shapiro DE, Patel K. PMID: 29694825.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    35. Management of Long-Term Complications of HIV Disease: Focus on Cardiovascular Disease. Top Antivir Med. 2018 Apr; 25(4):133-137. Currier JS. PMID: 29689541.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    36. Development and validation of an assay to analyze atazanavir in human hair via liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2018 Mar 15; 32(5):431-441. Phung N, Kuncze K, Okochi H, Louie A, Benet LZ, Ofokotun I, Haas DW, Currier JS, Chawana TD, Sheth AN, Bacchetti P, Gandhi M, Horng H. PMID: 29315954.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    37. Low Levels of Endothelial Progenitor Cells and Their Association with Systemic Inflammation and Monocyte Activation in Older HIV-Infected Men. AIDS Res Hum Retroviruses. 2018 01; 34(1):39-45. Seang S, Kelesidis T, Huynh D, Park S, Moe AA, Currier JS, Lake JE. PMID: 29226690.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    38. A Conversation Among the IAS-USA Board of Directors: Hot Topics and Emerging Data in HIV Research and Care. Top Antivir Med. 2017 Dec/Jan; 24(4):142-151. Benson CA, Currier JS, Del Rio C, Gallant JE, Gulick RM, Marrazzo JM, Richman DD, Saag MS, Schooley RT, Volberding PA. PMID: 28208122.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    39. Transgender Women Living with HIV Frequently Take Antiretroviral Therapy and/or Feminizing Hormone Therapy Differently Than Prescribed Due to Drug-Drug Interaction Concerns. LGBT Health. 2017 10; 4(5):371-375. Braun HM, Candelario J, Hanlon CL, Segura ER, Clark JL, Currier JS, Lake JE. PMID: 28876170.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    40. Antiretroviral initiation is associated with increased skeletal muscle area and fat content. AIDS. 2017 08 24; 31(13):1831-1838. Erlandson KM, Fiorillo S, Masawi F, Scherzinger A, McComsey GA, Lake JE, Stein JH, Currier JS, Brown TT. PMID: 28590329.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    41. Risk of Acute Myocardial Infarction Among Hepatitis C Virus (HCV)-Positive and HCV-Negative Men at Various Lipid Levels: Results From ERCHIVES. Clin Infect Dis. 2017 Aug 15; 65(4):557-565. Butt AA, Yan P, Chew KW, Currier J, Corey K, Chung RT, Shuaib A, Abou-Samra AB, Butler J, Freiberg MS. PMID: 28444148.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    42. Predictors of Impaired HDL Function in HIV-1 Infected Compared to Uninfected Individuals. J Acquir Immune Defic Syndr. 2017 07 01; 75(3):354-363. Kelesidis T, Oda MN, Borja MS, Yee Y, Ng KF, Huynh D, Elashoff D, Currier JS. PMID: 28346318.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    43. Subclinical myocardial disease by cardiac magnetic resonance imaging and spectroscopy in healthy HIV/Hepatitis C virus-coinfected persons. J Int Med Res. 2017 Dec; 45(6):1693-1707. Chew KW, Liu CY, Ambale-Venkatesh B, Liao D, Horwich TB, Lima JAC, Bluemke DA, Paul Finn J, Butt AA, Currier JS. PMID: 28606026.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    44. Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection. Clin Infect Dis. 2017 May 15; 64(10):1422-1429. Lake JE, Stanley TL, Apovian CM, Bhasin S, Brown TT, Capeau J, Currier JS, Dube MP, Falutz J, Grinspoon SK, Guaraldi G, Martinez E, McComsey GA, Sattler FR, Erlandson KM. PMID: 28329372.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    45. Randomized trial of stopping or continuing ART among postpartum women with pre-ART CD4 = 400 cells/mm3. PLoS One. 2017; 12(5):e0176009. Currier JS, Britto P, Hoffman RM, Brummel S, Masheto G, Joao E, Santos B, Aurpibul L, Losso M, Pierre MF, Weinberg A, Gnanashanmugam D, Chakhtoura N, Klingman K, Browning R, Coletti A, Mofenson L, Shapiro D, Pilotto J. PMID: 28489856.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    46. CROI 2017: Complications and Comorbidities of HIV Disease and Its Treatment. Top Antivir Med. 2017 May/Jun; 25(2):77-83. Currier JS, Havlir DV. PMID: 28598792.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    47. Factors associated with retention in Option B+ in Malawi: a case control study. J Int AIDS Soc. 2017 Apr 27; 20(1):21464. Hoffman RM, Phiri K, Parent J, Grotts J, Elashoff D, Kawale P, Yeatman S, Currier JS, Schooley A. PMID: 28453243.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    48. Changes in abdominal fat following antiretroviral therapy initiation in HIV-infected individuals correlate with waist circumference and self-reported changes. Antivir Ther. 2017; 22(7):577-586. Bhagwat P, Ofotokun I, McComsey GA, Brown TT, Moser C, Sugar CA, Currier JS. PMID: 28248190.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    49. Follow YOUR Heart: development of an evidence-based campaign empowering older women with HIV to participate in a large-scale cardiovascular disease prevention trial. HIV Clin Trials. 2017 03; 18(2):83-91. Zanni MV, Fitch K, Rivard C, Sanchez L, Douglas PS, Grinspoon S, Smeaton L, Currier JS, Looby SE. PMID: 28277924.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    50. HIV Transmission Risk Behavior in a Cohort of HIV-Infected Treatment-Naïve Men and Women in the United States. AIDS Behav. 2016 12; 20(12):2983-2995. Landovitz RJ, Tran TT, Cohn SE, Ofotokun I, Godfrey C, Kuritzkes DR, Lennox JL, Currier JS, Ribaudo HJ. PMID: 26979419.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    51. Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection. AIDS. 2016 11 13; 30(17):2625-2633. Kelesidis T, Jackson N, McComsey GA, Wang X, Elashoff D, Dube MP, Brown TT, Yang OO, Stein JH, Currier JS. PMID: 27603288.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    52. Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention. N Engl J Med. 2016 11 03; 375(18):1726-1737. Fowler MG, Qin M, Fiscus SA, Currier JS, Flynn PM, Chipato T, McIntyre J, Gnanashanmugam D, Siberry GK, Coletti AS, Taha TE, Klingman KL, Martinson FE, Owor M, Violari A, Moodley D, Theron GB, Bhosale R, Bobat R, Chi BH, Strehlau R, Mlay P, Loftis AJ, Browning R, Fenton T, Purdue L, Basar M, Shapiro DE, Mofenson LM. PMID: 27806243.
      View in: PubMed   Mentions: 50     Fields:    Translation:Humans
    53. Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy Initiation. J Acquir Immune Defic Syndr. 2016 10 01; 73(2):123-9. Mathad JS, Gupte N, Balagopal A, Asmuth D, Hakim J, Santos B, Riviere C, Hosseinipour M, Sugandhavesa P, Infante R, Pillay S, Cardoso SW, Mwelase N, Pawar J, Berendes S, Kumarasamy N, Andrade BB, Campbell TB, Currier JS, Cohn SE, Gupta A. PMID: 27258230.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    54. Telmisartan increases vascular reparative capacity in older HIV-infected adults: a pilot study. HIV Clin Trials. 2016 11; 17(6):225-232. Lake JE, Seang S, Kelesidis T, Currier JS, Yang OO. PMID: 27658740.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    55. Changes in plasma levels of oxidized lipoproteins and lipoprotein subfractions with atazanavir-, raltegravir-, darunavir-based initial antiviral therapy and associations with common carotid artery intima-media thickness: ACTG 5260s. Antivir Ther. 2017; 22(2):113-126. Kelesidis T, Tran TTT, Brown TT, Moser C, Ribaudo HJ, Dube MP, Yang OO, McComsey GA, Stein JH, Currier JS. PMID: 27661466.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    56. Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s. Open Forum Infect Dis. 2016 Sep; 3(3):ofw174. Dirajlal-Fargo S, Moser C, Brown TT, Kelesidis T, Dube MP, Stein JH, Currier J, McComsey GA. PMID: 27704026.
      View in: PubMed   Mentions:
    57. Traditional and HIV-specific risk factors for cardiovascular morbidity and mortality among HIV-infected adults in Brazil: a retrospective cohort study. BMC Infect Dis. 2016 Aug 08; 16:376. Diaz CM, Segura ER, Luz PM, Clark JL, Ribeiro SR, De Boni R, Eksterman L, Moreira R, Currier JS, Veloso VG, Grinsztejn B, Lake JE. PMID: 27503230.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    58. Soluble Levels of Receptor for Advanced Glycation Endproducts (RAGE) and Progression of Atherosclerosis in Individuals Infected with Human Immunodeficiency Virus: ACTG NWCS 332. Inflammation. 2016 Aug; 39(4):1354-62. Danoff A, Kendall MA, Currier JS, Kelesidis T, Schmidt AM, Aberg JA. PMID: 27216802.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    59. Reimann's "Habitual Hyperthermia" Responding to Hormone Therapy. Open Forum Infect Dis. 2016 Sep; 3(3):ofw127. Yang OO, Currier JS. PMID: 27800522.
      View in: PubMed   Mentions:
    60. Changes in Markers of T-Cell Senescence and Exhaustion With Atazanavir-, Raltegravir-, and Darunavir-Based Initial Antiviral Therapy: ACTG 5260s. J Infect Dis. 2016 09 01; 214(5):748-52. Kelesidis T, Moser C, Stein JH, Brown TT, Tran TT, Ribaudo HJ, Dube MP, Yang OO, Currier JS, McComsey GA. PMID: 27354367.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    61. Making waves: safety and efficacy of ART in women. Lancet HIV. 2016 09; 3(9):e398-e399. Currier JS, Lockman S. PMID: 27562733.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    62. HIV Infection and Carotid Artery Intima-media Thickness: Pooled Analyses Across 5 Cohorts of the NHLBI HIV-CVD Collaborative. Clin Infect Dis. 2016 07 15; 63(2):249-56. Hanna DB, Guo M, Bužková P, Miller TL, Post WS, Stein JH, Currier JS, Kronmal RA, Freiberg MS, Bennett SN, Shikuma CM, Anastos K, Li Y, Tracy RP, Hodis HN, Delaney JA, Kaplan RC. PMID: 27118787.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    63. Supporting Treatment Adherence Readiness through Training (START) for patients with HIV on antiretroviral therapy: study protocol for a randomized controlled trial. Trials. 2016 Mar 24; 17:162. Wagner GJ, Linnemayr S, Ghosh-Dastidar B, Currier JS, Hoffman R, Schneider S. PMID: 27009061.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    64. Body Composition Changes After Initiation of Raltegravir or Protease Inhibitors: ACTG A5260s. Clin Infect Dis. 2016 Apr 01; 62(7):853-62. McComsey GA, Moser C, Currier J, Ribaudo HJ, Paczuski P, Dubé MP, Kelesidis T, Rothenberg J, Stein JH, Brown TT. PMID: 26797215.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    65. A Cure for HIV Infection: "Not in My Lifetime" or "Just Around the Corner"? Pathog Immun. 2016; 1(1):154-164. Lederman MM, Cannon PM, Currier JS, June CH, Kiem HP, Kuritzkes DR, Lewin SR, Margolis DM, McCune JM, Mellors JW, Schacker TW, Sekaly RP, Tebas P, Walker BD, Douek DC. PMID: 27668293.
      View in: PubMed   Mentions:
    66. Vitamin D Levels and Markers of Inflammation and Metabolism in HIV-Infected Individuals on Suppressive Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2016 Mar; 32(3):247-54. Hoffman RM, Lake JE, Wilhalme HM, Tseng CH, Currier JS. PMID: 26569649.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    67. Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery. AIDS. 2015 Oct 23; 29(16):2121-9. Cillo AR, Hilldorfer BB, Lalama CM, McKinnon JE, Coombs RW, Tenorio AR, Fox L, Gandhi RT, Ribaudo H, Currier JS, Gulick RM, Wilkin TJ, Mellors JW. PMID: 26544577.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCellsCTClinical Trials
    68. Telmisartan to reduce cardiovascular risk in older HIV-infected adults: a pilot study. HIV Clin Trials. 2015 Oct; 16(5):197-206. Lake JE, Seang S, Kelesidis T, Liao DH, Hodis HN, Stein JH, Currier JS. PMID: 26360501.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    69. A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness. AIDS. 2015 Sep 10; 29(14):1775-83. Stein JH, Ribaudo HJ, Hodis HN, Brown TT, Tran TT, Yan M, Brodell EL, Kelesidis T, McComsey GA, Dube MP, Murphy RL, Currier JS. PMID: 26372383.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCellsCTClinical Trials
    70. Vitamin D3 supplementation in HIV infection: effectiveness and associations with antiretroviral therapy. Nutr J. 2015 Aug 18; 14:81. Coelho L, Cardoso SW, Luz PM, Hoffman RM, Mendonça L, Veloso VG, Currier JS, Grinsztejn B, Lake JE. PMID: 26283663.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    71. Screening for UGT1A1 Genotype in Study A5257 Would Have Markedly Reduced Premature Discontinuation of Atazanavir for Hyperbilirubinemia. Open Forum Infect Dis. 2015 Sep; 2(3):ofv085. Vardhanabhuti S, Ribaudo HJ, Landovitz RJ, Ofotokun I, Lennox JL, Currier JS, Olson LM, Haas DW. PMID: 26180834.
      View in: PubMed   Mentions:
    72. Comparison of HBV-active HAART regimens in an HIV-HBV multinational cohort: outcomes through 144 weeks. AIDS. 2015 Jun 19; 29(10):1173-82. Thio CL, Smeaton L, Hollabaugh K, Saulynas M, Hwang H, Saravanan S, Kulkarni S, Hakim J, Nyirenda M, Iqbal HS, Lalloo UG, Campbell TB, Lockman S, Currier JS. PMID: 26035319.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    73. Benefits of PrEP as an Adjunctive Method of HIV Prevention During Attempted Conception Between HIV-uninfected Women and HIV-infected Male Partners. J Infect Dis. 2015 Nov 15; 212(10):1534-43. Hoffman RM, Jaycocks A, Vardavas R, Wagner G, Lake JE, Mindry D, Currier JS, Landovitz RJ. PMID: 26092856.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    74. Extended-Release Niacin Versus Fenofibrate in HIV-Infected Participants With Low High-Density Lipoprotein Cholesterol: Effects on Endothelial Function, Lipoproteins, and Inflammation. Clin Infect Dis. 2015 Sep 01; 61(5):840-9. Dubé MP, Komarow L, Fichtenbaum CJ, Cadden JJ, Overton ET, Hodis HN, Currier JS, Stein JH. PMID: 25979307.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    75. Short Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected Persons. AIDS Res Hum Retroviruses. 2015 Jul; 31(7):718-22. Chew KW, Bhattacharya D, McGinnis KA, Horwich TB, Tseng CH, Currier JS, Butt AA. PMID: 25858663.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    76. Changes in Bone Mineral Density After Initiation of Antiretroviral Treatment With Tenofovir Disoproxil Fumarate/Emtricitabine Plus Atazanavir/Ritonavir, Darunavir/Ritonavir, or Raltegravir. J Infect Dis. 2015 Oct 15; 212(8):1241-9. Brown TT, Moser C, Currier JS, Ribaudo HJ, Rothenberg J, Kelesidis T, Yang O, Dubé MP, Murphy RL, Stein JH, McComsey GA. PMID: 25948863.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    77. Switch to Raltegravir From Protease Inhibitor or Nonnucleoside Reverse-Transcriptase Inhibitor Does not Reduce Visceral Fat In Human Immunodeficiency Virus-Infected Women With Central Adiposity. Open Forum Infect Dis. 2015 Apr; 2(2):ofv059. Lake JE, McComsey GA, Hulgan T, Wanke CA, Mangili A, Walmsley SL, Currier JS. PMID: 26380350.
      View in: PubMed   Mentions:
    78. Changes in Inflammation and Immune Activation With Atazanavir-, Raltegravir-, Darunavir-Based Initial Antiviral Therapy: ACTG 5260s. Clin Infect Dis. 2015 Aug 15; 61(4):651-60. Kelesidis T, Tran TT, Stein JH, Brown TT, Moser C, Ribaudo HJ, Dube MP, Murphy R, Yang OO, Currier JS, McComsey GA. PMID: 25904376.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    79. Concurrent Anemia and Elevated C-Reactive Protein Predicts HIV Clinical Treatment Failure, Including Tuberculosis, After Antiretroviral Therapy Initiation. Clin Infect Dis. 2015 Jul 01; 61(1):102-10. Shivakoti R, Yang WT, Gupte N, Berendes S, Rosa AL, Cardoso SW, Mwelase N, Kanyama C, Pillay S, Samaneka W, Riviere C, Sugandhavesa P, Santos B, Poongulali S, Tripathy S, Bollinger RC, Currier JS, Tang AM, Semba RD, Christian P, Campbell TB, Gupta A. PMID: 25828994.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    80. Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257. Clin Infect Dis. 2015 06 15; 60(12):1842-51. Ofotokun I, Na LH, Landovitz RJ, Ribaudo HJ, McComsey GA, Godfrey C, Aweeka F, Cohn SE, Sagar M, Kuritzkes DR, Brown TT, Patterson KB, Para MF, Leavitt RY, Villasis-Keever A, Baugh BP, Lennox JL, Currier JS. PMID: 25767256.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCellsCTClinical Trials
    81. The effect of hepatitis C virologic clearance on cardiovascular disease biomarkers in human immunodeficiency virus/hepatitis C virus coinfection. Open Forum Infect Dis. 2014 Dec; 1(3):ofu104. Chew KW, Hua L, Bhattacharya D, Butt AA, Bornfleth L, Chung RT, Andersen JW, Currier JS. PMID: 25734172.
      View in: PubMed   Mentions:
    82. A high throughput biochemical fluorometric method for measuring lipid peroxidation in HDL. PLoS One. 2014; 9(11):e111716. Kelesidis T, Roberts CK, Huynh D, Martínez-Maza O, Currier JS, Reddy ST, Yang OO. PMID: 25368900.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    83. Who Provides Primary Care? An Assessment of HIV Patient and Provider Practices and Preferences. J AIDS Clin Res. 2014 Nov; 5(11). Cheng QJ, Engelage EM, Grogan TR, Currier JS, Hoffman RM. PMID: 25914854.
      View in: PubMed   Mentions:
    84. Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial. Ann Intern Med. 2014 Oct 07; 161(7):461-71. Lennox JL, Landovitz RJ, Ribaudo HJ, Ofotokun I, Na LH, Godfrey C, Kuritzkes DR, Sagar M, Brown TT, Cohn SE, McComsey GA, Aweeka F, Fichtenbaum CJ, Presti RM, Koletar SL, Haas DW, Patterson KB, Benson CA, Baugh BP, Leavitt RY, Rooney JF, Seekins D, Currier JS. PMID: 25285539.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCellsCTClinical Trials
    85. Dyslipidemia and cardiovascular risk in human immunodeficiency virus infection. Endocrinol Metab Clin North Am. 2014 Sep; 43(3):665-84. Kelesidis T, Currier JS. PMID: 25169560.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    86. Proteinuria is associated with neurocognitive impairment in antiretroviral therapy treated HIV-infected individuals. J Acquir Immune Defic Syndr. 2014 Sep 01; 67(1):30-5. Kalayjian RC, Wu K, Evans S, Clifford DB, Pallaki M, Currier JS, Smryzynski M. PMID: 25118793.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    87. Role of RANKL-RANK/osteoprotegerin pathway in cardiovascular and bone disease associated with HIV infection. AIDS Rev. 2014 Jul-Sep; 16(3):123-33. Kelesidis T, Currier JS, Yang OO, Brown TT. PMID: 25102334.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    88. Predictors of suboptimal CD4 response among women achieving virologic suppression in a randomized antiretroviral treatment trial, Africa. BMC Infect Dis. 2014 Jun 17; 14:331. Asmelash A, Zheng Y, Kaloustian KW, Shaffer D, Sawe F, Ogwu A, Salata R, Currier J, Hughes MD, Lockman S. PMID: 24938526.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    89. Urinary eicosanoid metabolites in HIV-infected women with central obesity switching to raltegravir: an analysis from the women, integrase, and fat accumulation trial. Mediators Inflamm. 2014; 2014:803095. Hulgan T, Boger MS, Liao DH, McComsey GA, Wanke CA, Mangili A, Walmsley SL, McCreath H, Milne GL, Sanchez SC, Currier JS, Lake JE. PMID: 24991090.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    90. Cardiovascular disease risk factors in HIV-infected women after initiation of lopinavir/ritonavir- and nevirapine-based antiretroviral therapy in Sub-Saharan Africa: A5208 (OCTANE). J Acquir Immune Defic Syndr. 2014 Jun 01; 66(2):155-63. Shaffer D, Hughes MD, Sawe F, Bao Y, Moses A, Hogg E, Lockman S, Currier J. PMID: 24562349.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    91. Antiretroviral therapy and efficacy after virologic failure on first-line boosted protease inhibitor regimens. Clin Infect Dis. 2014 Sep 15; 59(6):888-96. Zheng Y, Hughes MD, Lockman S, Benson CA, Hosseinipour MC, Campbell TB, Gulick RM, Daar ES, Sax PE, Riddler SA, Haubrich R, Salata RA, Currier JS. PMID: 24842909.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    92. Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapine. AIDS. 2014 May 15; 28(8):1135-42. Mwafongo A, Nkanaunena K, Zheng Y, Hogg E, Samaneka W, Mulenga L, Siika A, Currier J, Lockman S, Hughes MD, Hosseinipour M. PMID: 24445367.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsCTClinical Trials
    93. Arterial disease in patients with human immunodeficiency virus infection: what has imaging taught us? JACC Cardiovasc Imaging. 2014 May; 7(5):515-25. Stein JH, Currier JS, Hsue PY. PMID: 24831212.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    94. HIV and atherosclerosis: moving from associations to mechanisms and interventions. Ann Intern Med. 2014 Apr 01; 160(7):509-10. Currier JS, Stein JH. PMID: 24687073.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    95. Immune activation markers in peripartum women in Botswana: association with feeding strategy and maternal morbidity. PLoS One. 2014; 9(3):e89928. Russell ES, Mohammed T, Smeaton L, Jorowe B, MacLeod IJ, Hoffman RM, Currier JS, Moyo S, Essex M, Lockman S. PMID: 24657960.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    96. HDL redox activity is increased in HIV-infected men in association with macrophage activation and non-calcified coronary atherosclerotic plaque. Antivir Ther. 2014; 19(8):805-811. Zanni MV, Kelesidis T, Fitzgerald ML, Lo J, Abbara S, Wai B, Marmarelis E, Hernandez NJ, Yang OO, Currier JS, Grinspoon SK. PMID: 24535655.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    97. Metabolic disease in HIV infection. Lancet Infect Dis. 2013 Nov; 13(11):964-75. Lake JE, Currier JS. PMID: 24156897.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCells
    98. Biomarkers from late pregnancy to 6 weeks postpartum in HIV-infected women who continue versus discontinue antiretroviral therapy after delivery. J Acquir Immune Defic Syndr. 2013 Aug 15; 63(5):593-601. Hoffman RM, Leister E, Kacanek D, Shapiro DE, Read JS, Bryson Y, Currier JS. PMID: 23714738.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    99. Body composition, soluble markers of inflammation, and bone mineral density in antiretroviral therapy-naive HIV-1-infected individuals. J Acquir Immune Defic Syndr. 2013 Jul 01; 63(3):323-30. Brown TT, Chen Y, Currier JS, Ribaudo HJ, Rothenberg J, Dubé MP, Murphy R, Stein JH, McComsey GA. PMID: 23591634.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCellsCTClinical Trials
    100. Insights on GRACE (Gender, Race, And Clinical Experience) from the patient's perspective: GRACE participant survey. AIDS Patient Care STDS. 2013 Jun; 27(6):352-62. Squires K, Feinberg J, Bridge DA, Currier J, Ryan R, Seyedkazemi S, Dayaram YK, Mrus J. PMID: 23701200.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    101. Ultrasonographic measures of cardiovascular disease risk in antiretroviral treatment-naive individuals with HIV infection. AIDS. 2013 Mar 27; 27(6):929-37. Stein JH, Brown TT, Ribaudo HJ, Chen Y, Yan M, Lauer-Brodell E, McComsey GA, Dubé MP, Murphy RL, Hodis HN, Currier JS. PMID: 23196938.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    102. A pilot study of telmisartan for visceral adiposity in HIV infection: the metabolic abnormalities, telmisartan, and HIV infection (MATH) trial. PLoS One. 2013; 8(3):e58135. Lake JE, Tseng CH, Currier JS. PMID: 23516440.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    103. Dysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adults. Lipids Health Dis. 2013 Mar 05; 12:23. Kelesidis T, Yang OO, Kendall MA, Hodis HN, Currier JS. PMID: 23510548.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    104. Perturbations of circulating levels of RANKL-osteoprotegerin axis in relation to lipids and progression of atherosclerosis in HIV-infected and -uninfected adults: ACTG NWCS 332/A5078 Study. AIDS Res Hum Retroviruses. 2013 Jun; 29(6):938-48. Kelesidis T, Kendall MA, Yang OO, Hodis H, Currier JS. PMID: 23351153.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    105. Moderate prevalence of transmitted drug resistance mutations among antiretroviral-naive HIV-infected pregnant women in Rio de Janeiro, Brazil. AIDS Res Hum Retroviruses. 2013 Apr; 29(4):681-6. Pilotto JH, Grinsztejn B, Veloso VG, Velasque LS, Friedman RK, Moreira RI, Rodrigues-Pedro A, Oliveira SM, Currier JS, Morgado MG. PMID: 23259924.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    106. Characterization of HIV-HBV coinfection in a multinational HIV-infected cohort. AIDS. 2013 Jan 14; 27(2):191-201. Thio CL, Smeaton L, Saulynas M, Hwang H, Saravanan S, Saravan S, Kulkarni S, Hakim J, Nyirenda M, Iqbal HS, Lalloo UG, Mehta AS, Hollabaugh K, Campbell TB, Lockman S, Currier JS. PMID: 23032418.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    107. Biomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infection. J Infect Dis. 2012 Nov 15; 206(10):1558-67. Kelesidis T, Kendall MA, Yang OO, Hodis HN, Currier JS. PMID: 23066162.
      View in: PubMed   Mentions: 91     Fields:    Translation:HumansCells
    108. A randomized trial of Raltegravir replacement for protease inhibitor or non-nucleoside reverse transcriptase inhibitor in HIV-infected women with lipohypertrophy. AIDS Patient Care STDS. 2012 Sep; 26(9):532-40. Lake JE, McComsey GA, Hulgan TM, Wanke CA, Mangili A, Walmsley SL, Boger MS, Turner RR, McCreath HE, Currier JS. PMID: 22823027.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    109. HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr. 2012 Jul 01; 60 Suppl 1:S1-18. High KP, Brennan-Ing M, Clifford DB, Cohen MH, Currier J, Deeks SG, Deren S, Effros RB, Gebo K, Goronzy JJ, Justice AC, Landay A, Levin J, Miotti PG, Munk RJ, Nass H, Rinaldo CR, Shlipak MG, Tracy R, Valcour V, Vance DE, Walston JD, Volberding P. PMID: 22688010.
      View in: PubMed   Mentions: 186     Fields:    Translation:Humans
    110. Assessing darunavir/ritonavir-based therapy in a racially diverse population: 48-week outcomes from GRACE. J Natl Med Assoc. 2012 Jul-Aug; 104(7-8):366-76. Smith KY, Garcia F, Kumar P, Currier JS, Ryan R, Falcon R, Mrus J, Squires K. PMID: 23092052.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    111. A pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4? T-cell recovery despite sustained virologic suppression: ACTG A5256. J Infect Dis. 2012 Aug 15; 206(4):534-42. Wilkin TJ, Lalama CM, McKinnon J, Gandhi RT, Lin N, Landay A, Ribaudo H, Fox L, Currier JS, Mellors JW, Gulick R, Tenorio AR. PMID: 22740718.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCellsCTClinical Trials
    112. Nevirapine- versus lopinavir/ritonavir-based initial therapy for HIV-1 infection among women in Africa: a randomized trial. PLoS Med. 2012; 9(6):e1001236. Lockman S, Hughes M, Sawe F, Zheng Y, McIntyre J, Chipato T, Asmelash A, Rassool M, Kimaiyo S, Shaffer D, Hosseinipour M, Mohapi L, Ssali F, Chibowa M, Amod F, Halvas E, Hogg E, Alston-Smith B, Smith L, Schooley R, Mellors J, Currier J. PMID: 22719231.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    113. Infant outcomes after maternal antiretroviral exposure in resource-limited settings. Pediatrics. 2012 Jun; 129(6):e1525-32. Nielsen-Saines K, Komarow L, Cu-Uvin S, Jourdain G, Klingman KL, Shapiro DE, Mofenson L, Moran L, Campbell TB, Hitti J, Fiscus S, Currier J. PMID: 22585772.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCellsCTClinical Trials
    114. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Los Angeles County. J Med Virol. 2012 May; 84(5):777-85. Kelesidis T, Humphries R, Terashita D, Eshaghian S, Territo MC, Said J, Lewinski M, Currier JS, Pegues D. PMID: 22431026.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    115. Nevirapine pharmacokinetics and risk of rash and hepatitis among HIV-infected sub-Saharan African women. AIDS. 2012 Apr 24; 26(7):833-41. Dong BJ, Zheng Y, Hughes MD, Frymoyer A, Verotta D, Lizak P, Sawe F, Currier JS, Lockman S, Aweeka FT. PMID: 22301417.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCTClinical Trials
    116. The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatment. PLoS One. 2012; 7(4):e34399. Skinner-Adams TS, Butterworth AS, Porter KA, D'Amico R, Sawe F, Shaffer D, Siika A, Hosseinipour MC, Stringer E, Currier JS, Chipato T, Salata R, Lockman S, Eron JJ, Meshnick SR, McCarthy JS. PMID: 22509297.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    117. HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study. Antimicrob Agents Chemother. 2012 Feb; 56(2):995-1000. Porter KA, Cole SR, Eron JJ, Zheng Y, Hughes MD, Lockman S, Poole C, Skinner-Adams TS, Hosseinipour M, Shaffer D, D'Amico R, Sawe FK, Siika A, Stringer E, Currier JS, Chipato T, Salata R, McCarthy JS, Meshnick SR. PMID: 22123685.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsCTClinical Trials
    118. A biochemical fluorometric method for assessing the oxidative properties of HDL. J Lipid Res. 2011 Dec; 52(12):2341-51. Kelesidis T, Currier JS, Huynh D, Meriwether D, Charles-Schoeman C, Reddy ST, Fogelman AM, Navab M, Yang OO. PMID: 21957198.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    119. Health-related quality of life in the gender, race, and clinical experience trial. AIDS Res Treat. 2011; 2011:349165. Feinberg J, Saag M, Squires K, Currier J, Ryan R, Coate B, Mrus J. PMID: 21904672.
      View in: PubMed   Mentions:
    120. Participation of women in HIV clinical trials: the IPEC-FIOCRUZ experience. HIV AIDS (Auckl). 2011; 3:61-8. Lake JE, Friedman RK, Cunha CB, Cardoso SW, Veloso VG, Currier JS, Grinsztejn B. PMID: 22096408.
      View in: PubMed   Mentions:
    121. Regional fat deposition and cardiovascular risk in HIV infection: the FRAM study. AIDS Care. 2011 Aug; 23(8):929-38. Lake JE, Wohl D, Scherzer R, Grunfeld C, Tien PC, Sidney S, Currier JS. PMID: 21767228.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    122. Recruitment and retention of diverse populations in antiretroviral clinical trials: practical applications from the gender, race and clinical experience study. J Womens Health (Larchmt). 2011 Jul; 20(7):1043-50. Falcon R, Bridge DA, Currier J, Squires K, Hagins D, Schaible D, Ryan R, Mrus J. PMID: 21663416.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    123. Baseline immune phenotypes and CD4+ T lymphocyte responses to antiretroviral therapy in younger versus older HIV-infected individuals. J Clin Immunol. 2011 Oct; 31(5):873-81. Hoffman RM, Jamieson BD, Bosch RJ, Currier J, Kitchen CM, Schmid I, Zhu Y, Bennett K, Mitsuyasu R. PMID: 21643890.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    124. Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362. AIDS Care. 2011 Jun; 23(6):775-85. Cohn SE, Jiang H, McCutchan JA, Koletar SL, Murphy RL, Robertson KR, de St Maurice AM, Currier JS, Williams PL. PMID: 21293986.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    125. Effects of darunavir/ritonavir-based therapy on metabolic and anthropometric parameters in women and men over 48 weeks. AIDS Patient Care STDS. 2011 Jun; 25(6):333-40. Currier JS, Martorell C, Osiyemi O, Yin MT, Ryan R, De La Rosa G, Mrus J. PMID: 21612545.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    126. Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine. Proc Natl Acad Sci U S A. 2011 May 31; 108(22):9202-7. Boltz VF, Zheng Y, Lockman S, Hong F, Halvas EK, McIntyre J, Currier JS, Chibowa MC, Kanyama C, Nair A, Owino-Ong'or W, Hughes M, Coffin JM, Mellors JW. PMID: 21576473.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    127. Complications of HIV disease and antiretroviral therapy. Top Antivir Med. 2011 May-Jun; 19(2):58-68. Luetkemeyer AF, Havlir DV, Currier JS. PMID: 21868823.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    128. Pregnancy rates and predictors in women with HIV/AIDS in Rio de Janeiro, Southeastern Brazil. Rev Saude Publica. 2011 Apr; 45(2):373-81. Friedman RK, Bastos FI, Leite IC, Veloso VG, Moreira RI, Cardoso SW, Andrade AC, Sampaio MC, Currier J, Grinsztejn B. PMID: 21412574.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    129. HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL. Lipids Health Dis. 2011 Feb 23; 10:35. Kelesidis T, Yang OO, Currier JS, Navab K, Fogelman AM, Navab M. PMID: 21345230.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    130. First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial. AIDS. 2011 Feb 20; 25(4):479-92. Ciaranello AL, Lockman S, Freedberg KA, Hughes M, Chu J, Currier J, Wood R, Holmes CB, Pillay S, Conradie F, McIntyre J, Losina E, Walensky RP. PMID: 21293199.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    131. Sex differences in lopinavir and ritonavir pharmacokinetics among HIV-infected women and men. J Clin Pharmacol. 2011 Dec; 51(12):1665-73. Umeh OC, Currier JS, Park JG, Cramer Y, Hermes AE, Fletcher CV. PMID: 21233301.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    132. Maternal outcomes after HAART for the prevention of mother-to-child transmission in HIV-infected women in Brazil. Antivir Ther. 2011; 16(3):349-56. Pilotto JH, Velasque LS, Friedman RK, Moreira RI, Veloso VG, Grinsztejn B, Morgado MG, Watts DH, Currier JS, Hoffman RM. PMID: 21555817.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    133. Sex-associated differences in pre-antiretroviral therapy plasma HIV-1 RNA in diverse areas of the world vary by CD4(+) T-cell count. Antivir Ther. 2011; 16(7):1057-62. Grinsztejn B, Smeaton L, Barnett R, Klingman K, Hakim J, Flanigan T, Kumarasamy N, Campbell T, Currier J. PMID: 22024521.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    134. A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen. HIV Clin Trials. 2010 Nov-Dec; 11(6):312-24. Hammer SM, Ribaudo H, Bassett R, Mellors JW, Demeter LM, Coombs RW, Currier J, Morse GD, Gerber JG, Martinez AI, Spreen W, Fischl MA, Squires KE. PMID: 21239359.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    135. Switching antiretroviral therapy to minimize metabolic complications. HIV Ther. 2010 Nov; 4(6):693-711. Lake JE, Currier JS. PMID: 22171239.
      View in: PubMed   Mentions:
    136. Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229. AIDS. 2010 Oct 23; 24(16):2507-15. McComsey GA, Walker UA, Budhathoki CB, Su Z, Currier JS, Kosmiski L, Naini LG, Charles S, Medvik K, Aberg JA. PMID: 20827170.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    137. Antiretroviral therapies in women after single-dose nevirapine exposure. N Engl J Med. 2010 Oct 14; 363(16):1499-509. Lockman S, Hughes MD, McIntyre J, Zheng Y, Chipato T, Conradie F, Sawe F, Asmelash A, Hosseinipour MC, Mohapi L, Stringer E, Mngqibisa R, Siika A, Atwine D, Hakim J, Shaffer D, Kanyama C, Wools-Kaloustian K, Salata RA, Hogg E, Alston-Smith B, Walawander A, Purcelle-Smith E, Eshleman S, Rooney J, Rahim S, Mellors JW, Schooley RT, Currier JS. PMID: 20942666.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCells
    138. Sex-based outcomes of darunavir-ritonavir therapy: a single-group trial. Ann Intern Med. 2010 Sep 21; 153(6):349-57. Currier J, Averitt Bridge D, Hagins D, Zorrilla CD, Feinberg J, Ryan R, Falcon R, Tennenberg A, Mrus J, Squires K. PMID: 20855799.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCellsCTClinical Trials
    139. Associations of antiretroviral drug use and HIV-specific risk factors with carotid intima-media thickness. AIDS. 2010 Sep 10; 24(14):2201-9. Delaney JA, Scherzer R, Biggs ML, Shliplak MG, Polak JF, Currier JS, Kronmal RA, Wanke C, Bacchetti P, O'leary D, Tien PC, Grunfeld C. PMID: 20671544.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    140. Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2010 May 01; 54(1):35-41. Hoffman RM, Black V, Technau K, van der Merwe KJ, Currier J, Coovadia A, Chersich M. PMID: 20216425.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    141. Complications of HIV disease and antiretroviral treatment. Top HIV Med. 2010 Apr-May; 18(2):57-65. Luetkemeyer AF, Havlir DV, Currier JS. PMID: 20516525.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    142. Clinical practice. Postexposure prophylaxis for HIV infection. N Engl J Med. 2009 Oct 29; 361(18):1768-75. Landovitz RJ, Currier JS. PMID: 19864675.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansPHPublic Health
    143. Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS. 2009 Sep 10; 23(14):1841-9. Grunfeld C, Delaney JA, Wanke C, Currier JS, Scherzer R, Biggs ML, Tien PC, Shlipak MG, Sidney S, Polak JF, O'Leary D, Bacchetti P, Kronmal RA. PMID: 19455012.
      View in: PubMed   Mentions: 123     Fields:    Translation:Humans
    144. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2009 Sep 01; 49(5):651-81. Aberg JA, Kaplan JE, Libman H, Emmanuel P, Anderson JR, Stone VE, Oleske JM, Currier JS, Gallant JE. PMID: 19640227.
      View in: PubMed   Mentions: 126     Fields:    Translation:Humans
    145. Update on cardiovascular complications in HIV infection. Top HIV Med. 2009 Jul-Aug; 17(3):98-103. Currier JS. PMID: 19675367.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    146. Availability of HIV postexposure prophylaxis services in Los Angeles County. Clin Infect Dis. 2009 Jun 01; 48(11):1624-7. Landovitz RJ, Combs KB, Currier JS. PMID: 19400685.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    147. Complications of HIV disease and antiretroviral therapy. Top HIV Med. 2009 Apr-May; 17(2):57-67. Currier JS, Havlir DV. PMID: 19401608.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    148. Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211. Clin Infect Dis. 2009 Mar 01; 48(5):642-9. Tsibris AM, Paredes R, Chadburn A, Su Z, Henrich TJ, Krambrink A, Hughes MD, Aberg JA, Currier JS, Tashima K, Godfrey C, Greaves W, Flexner C, Skolnik PR, Wilkin TJ, Gulick RM, Kuritzkes DR. PMID: 19191652.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCellsCTClinical Trials
    149. Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy. J Clin Lipidol. 2008 Dec; 2(6):464-471. Stein JH, Komarow L, Cotter BR, Currier JS, Dubé MP, Fichtenbaum CJ, Gerschenson M, Mitchell CK, Murphy RL, Squires K, Parker RA, Torriani FJ. PMID: 19956354.
      View in: PubMed   Mentions: 14     Fields:    
    150. Safety and efficacy of initiating highly active antiretroviral therapy in an integrated antenatal and HIV clinic in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2008 Nov 01; 49(3):276-81. Black V, Hoffman RM, Sugar CA, Menon P, Venter F, Currier JS, Rees H. PMID: 18845949.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    151. Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s. J Am Coll Cardiol. 2008 Aug 12; 52(7):569-76. Torriani FJ, Komarow L, Parker RA, Cotter BR, Currier JS, Dubé MP, Fichtenbaum CJ, Gerschenson M, Mitchell CK, Murphy RL, Squires K, Stein JH. PMID: 18687253.
      View in: PubMed   Mentions: 123     Fields:    Translation:HumansCells
    152. Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. Circulation. 2008 Jul 08; 118(2):e29-35. Currier JS, Lundgren JD, Carr A, Klein D, Sabin CA, Sax PE, Schouten JT, Smieja M. PMID: 18566319.
      View in: PubMed   Mentions: 115     Fields:    Translation:Humans
    153. State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/AIDS: executive summary. Circulation. 2008 Jul 08; 118(2):198-210. Grinspoon SK, Grunfeld C, Kotler DP, Currier JS, Lundgren JD, Dubé MP, Lipshultz SE, Hsue PY, Squires K, Schambelan M, Wilson PW, Yarasheski KE, Hadigan CM, Stein JH, Eckel RH. PMID: 18566320.
      View in: PubMed   Mentions: 68     Fields:    Translation:Humans
    154. Calcification of the internal elastic lamina of coronary arteries. Mod Pathol. 2008 Aug; 21(8):1019-28. Micheletti RG, Fishbein GA, Currier JS, Singer EJ, Fishbein MC. PMID: 18536656.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    155. Guidelines for managing cardiovascular risk: an evolving area. Curr Opin HIV AIDS. 2008 May; 3(3):205-6. Currier JS, Lundgren JD. PMID: 19372967.
      View in: PubMed   Mentions: 3     Fields:    
    156. Regional adipose tissue and lipid and lipoprotein levels in HIV-infected women. J Acquir Immune Defic Syndr. 2008 May 01; 48(1):35-43. Currier J, Scherzer R, Bacchetti P, Heymsfield S, Lee D, Sidney S, Tien PC. PMID: 18197118.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    157. Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Complications of HIV disease and therapy. Top HIV Med. 2008 Apr-May; 16(1):23-30. Currier JS, Havlir DV. PMID: 18441380.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    158. Coronary atherosclerotic lesions in human immunodeficiency virus-infected patients: a histopathologic study. Cardiovasc Pathol. 2009 Jan-Feb; 18(1):28-36. Micheletti RG, Fishbein GA, Fishbein MC, Singer EJ, Weiss RE, Jeffries RA, Currier JS. PMID: 18402832.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    159. Primary human immunodeficiency virus type 1 (HIV-1) infection during HIV-1 Gag vaccination. J Virol. 2008 Mar; 82(6):2784-91. Balamurugan A, Lewis MJ, Kitchen CM, Robertson MN, Shiver JW, Daar ES, Pitt J, Ali A, Ng HL, Currier JS, Yang OO. PMID: 18199650.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    160. Mönckeberg sclerosis revisited: a clarification of the histologic definition of Mönckeberg sclerosis. Arch Pathol Lab Med. 2008 Jan; 132(1):43-7. Micheletti RG, Fishbein GA, Currier JS, Fishbein MC. PMID: 18181672.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    161. Antiviral activity and safety of aplaviroc with lamivudine/zidovudine in HIV-infected, therapy-naive patients: the ASCENT (CCR102881) study. Antivir Ther. 2008; 13(2):297-306. Currier J, Lazzarin A, Sloan L, Clumeck N, Slims J, McCarty D, Steel H, Kleim JP, Bonny T, Millard J. PMID: 18505181.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    162. Evaluation of sex differences of fosamprenavir (with and without ritonavir) in HIV-infected men and women. HIV Clin Trials. 2007 Nov-Dec; 8(6):371-80. Hoffman RM, Umeh OC, Garris C, Givens N, Currier JS. PMID: 18042502.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    163. Atherosclerotic oxalosis in coronary arteries. Cardiovasc Pathol. 2008 Mar-Apr; 17(2):117-23. Fishbein GA, Micheletti RG, Currier JS, Singer E, Fishbein MC. PMID: 18329558.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    164. Sex differences in antiretroviral therapy toxicity: lactic acidosis, stavudine, and women. Clin Infect Dis. 2007 Jul 15; 45(2):261-2. Currier JS. PMID: 17578789.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    165. HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patients. AIDS. 2007 May 31; 21(9):1109-17. McCutchan JA, Wu JW, Robertson K, Koletar SL, Ellis RJ, Cohn S, Taylor M, Woods S, Heaton R, Currier J, Williams PL. PMID: 17502721.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    166. Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults. AIDS. 2007 May 31; 21(9):1137-45. Currier JS, Kendall MA, Henry WK, Alston-Smith B, Torriani FJ, Tebas P, Li Y, Hodis HN. PMID: 17502724.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    167. Report from the 14th Retrovirus Conference. Metabolic complications: lipoatrophy, lipohypertrophy, and cardiovascular risk. AIDS Clin Care. 2007 May; 19(5):40-1. Currier J. PMID: 18398989.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    168. Complications of HIV disease and therapy. Top HIV Med. 2007 Apr-May; 15(2):40-7. Currier JS, Havlir DV. PMID: 17485786.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    169. Management of antiretroviral treatment-related complications. Infect Dis Clin North Am. 2007 Mar; 21(1):103-32, ix. Hoffman RM, Currier JS. PMID: 17502232.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    170. Sex differences in pharmacokinetics and toxicity of antiretroviral therapy. Expert Opin Drug Metab Toxicol. 2006 Apr; 2(2):273-83. Umeh OC, Currier JS. PMID: 16866613.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    171. Complications of HIV disease and antiretroviral therapy. Top HIV Med. 2006 Mar-Apr; 14(1):27-35. Havlir DV, Currier JS. PMID: 16641525.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    172. Response to: 'carotid intima-media thickness: assessment of sub-clinical atherosclerosis in HIV-infected patients'. AIDS. 2006 Jan 09; 20(2):311. Currier JS, Kendall MA, Henry WK, Torriani FJ, Hodis HN. PMID: 16511437.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    173. Report from the 7th International Lipodystrophy Meeting. AIDS Clin Care. 2006 Jan; 18(1):11-2. Currier J. PMID: 16555403.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    174. Lipids, metabolic syndrome, and risk factors for future cardiovascular disease among HIV-infected patients. Curr HIV/AIDS Rep. 2005 Aug; 2(3):132-9. Umeh OC, Currier JS. PMID: 16091260.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    175. Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure. AIDS. 2005 Jun 10; 19(9):927-33. Currier JS, Kendall MA, Zackin R, Henry WK, Alston-Smith B, Torriani FJ, Schouten J, Mickelberg K, Li Y, Hodis HN. PMID: 15905673.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    176. Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial. Arch Intern Med. 2005 Mar 14; 165(5):578-85. Mulligan K, Zackin R, Clark RA, Alston-Smith B, Liu T, Sattler FR, Delvers TB, Currier JS. PMID: 15767536.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    177. Complications of HIV disease and antiretroviral therapy. Top HIV Med. 2005 Mar-Apr; 13(1):16-23. Currier JS, Havlir DV. PMID: 15849369.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    178. Sex Differences in HIV: Natural History, Pharmacokinetics, and Drug Toxicity. Curr Infect Dis Rep. 2005 Jan; 7(1):73-78. Umeh OC, Currier JS. PMID: 15610674.
      View in: PubMed   Mentions:
    179. C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056s. AIDS. 2004 Dec 03; 18(18):2434-7. Henry K, Kitch D, Dube M, Zackin R, Parker RA, Sprecher D, Hammer S, Currier J. PMID: 15622323.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCellsCTClinical Trials
    180. HIV health care services for Mexican migrants. J Acquir Immune Defic Syndr. 2004 Nov 01; 37 Suppl 4:S240-51. Solorio MR, Currier J, Cunningham W. PMID: 15722866.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    181. Long-term follow-up of HIV-infected individuals who have significant increases in CD4+ cell counts during antiretroviral therapy. Clin Infect Dis. 2004 Nov 15; 39(10):1500-6. Koletar SL, Williams PL, Wu J, McCutchan JA, Cohn SE, Murphy RL, Lederman HM, Currier JS. PMID: 15546087.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    182. The correlation between plasma concentrations of protease inhibitors, medication adherence and virological outcome in HIV-infected patients. Antivir Ther. 2004 Oct; 9(5):753-61. Yasuda JM, Miller C, Currier JS, Forthal DN, Kemper CA, Beall GN, Tilles JG, Capparelli EV, McCutchan JA, Haubrich RH. PMID: 15535413.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCellsCTClinical Trials
    183. Meeting report from the XV International AIDS Conference. Metabolic complications. AIDS Clin Care. 2004 Sep; 16(9):73-4. Currier J. PMID: 15540318.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    184. Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2004 Sep 01; 39(5):609-29. Aberg JA, Gallant JE, Anderson J, Oleske JM, Libman H, Currier JS, Stone VE, Kaplan JE. PMID: 15356773.
      View in: PubMed   Mentions: 50     Fields:    Translation:Cells
    185. Report from the 11th conference on retroviruses and opportunistic infections. Metabolic complications. AIDS Clin Care. 2004 Apr; 16(4):29-32. Currier J. PMID: 15124585.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    186. Report from the 11th conference on retroviruses and opportunistic infections. Neurology of HIV. AIDS Clin Care. 2004 Apr; 16(4):33-4. Currier J. PMID: 15124587.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    187. Complications of HIV disease and antiretroviral therapy. Highlights of the 11th Conference on Retroviruses and Opportunistic Infections, February 8-11, 2004, San Francisco, California, USA. Top HIV Med. 2004 Mar-Apr; 12(1):31-45. Currier JS, Havlir DV. PMID: 15111728.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    188. Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion. J Infect Dis. 2003 Dec 15; 188(12):1794-803. Lederman HM, Williams PL, Wu JW, Evans TG, Cohn SE, McCutchan JA, Koletar SL, Hafner R, Connick E, Valentine FT, McElrath MJ, Roberts NJ, Currier JS. PMID: 14673757.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCellsCTClinical Trials
    189. A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir. Antivir Ther. 2003 Dec; 8(6):507-18. Hammer SM, Bassett R, Squires KE, Fischl MA, Demeter LM, Currier JS, Mellors JW, Morse GD, Eron JJ, Santana JL, DeGruttola V. PMID: 14760884.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsCTClinical Trials
    190. A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome. Clin Infect Dis. 2003 Nov 01; 37(9):1234-43. Benson CA, Williams PL, Currier JS, Holland F, Mahon LF, MacGregor RR, Inderlied CB, Flexner C, Neidig J, Chaisson R, Notario GF, Hafner R. PMID: 14557969.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsCTClinical Trials
    191. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clin Infect Dis. 2003 Sep 01; 37(5):613-27. Dubé MP, Stein JH, Aberg JA, Fichtenbaum CJ, Gerber JG, Tashima KT, Henry WK, Currier JS, Sprecher D, Glesby MJ. PMID: 12942391.
      View in: PubMed   Mentions: 134     Fields:    Translation:Humans
    192. Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr. 2003 Aug 01; 33(4):506-12. Currier JS, Taylor A, Boyd F, Dezii CM, Kawabata H, Burtcel B, Maa JF, Hodder S. PMID: 12869840.
      View in: PubMed   Mentions: 166     Fields:    Translation:Humans
    193. Complications of HIV infection and antiretroviral therapy. Top HIV Med. 2003 May-Jun; 11(3):86-91. Havlir DV, Currier JS. PMID: 12837967.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    194. Current management challenges in HIV: tolerability of antiretrovirals and metabolic complications. AIDS Patient Care STDS. 2003 May; 17(5):221-33. Hicks C, Currier J, Sax P, Sherer R, Wanke C. PMID: 12816616.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    195. A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex: AIDS Clinical Trial Group 393 Study Team. J Infect Dis. 2003 Apr 01; 187(7):1046-52. Aberg JA, Williams PL, Liu T, Lederman HM, Hafner R, Torriani FJ, Lennox JL, Dube MP, MacGregor RR, Currier JS. PMID: 12660918.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsCTClinical Trials
    196. Steady-state pharmacokinetic interaction of modified-dose indinavir and rifabutin. Clin Pharmacol Ther. 2003 Mar; 73(3):159-69. Hamzeh FM, Benson C, Gerber J, Currier J, McCrea J, Deutsch P, Ruan P, Wu H, Lee J, Flexner C. PMID: 12621381.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    197. Cardiovascular risk factors and antiretroviral therapy. N Engl J Med. 2003 Feb 20; 348(8):679-80. Kuritzkes DR, Currier J. PMID: 12594310.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    198. HIV Infection in Women: Selected Issues in Pregnancy. Top HIV Med. 2002 Nov-Dec; 10(5):16-20. Currier JS. PMID: 12717051.
      View in: PubMed   Mentions:    Fields:    
    199. HIV risk behaviors among African American men in Los Angeles County who self-identify as heterosexual. J Acquir Immune Defic Syndr. 2002 Nov 01; 31(3):354-60. Wohl AR, Johnson DF, Lu S, Jordan W, Beall G, Currier J, Simon PA. PMID: 12439213.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    200. Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel. J Acquir Immune Defic Syndr. 2002 Nov 01; 31(3):257-75. Schambelan M, Benson CA, Carr A, Currier JS, Dubé MP, Gerber JG, Grinspoon SK, Grunfeld C, Kotler DP, Mulligan K, Powderly WG, Saag MS. PMID: 12439201.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCells
    201. Report on the XIV International AIDS Conference. AIDS Clin Care. 2002 Sep; 14(9):77-85. Abdool Karim SS, Currier J, del Rio C, Feinberg J, Friedland GH, Sax PE, Zuger A. PMID: 12236208.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    202. Cardiovascular risk associated with HIV therapy. J Acquir Immune Defic Syndr. 2002 Sep 01; 31 Suppl 1:S16-23; discussion S24-5. Currier JS. PMID: 12218440.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    203. Localized osteomyelitis due to Mycobacterium avium complex in patients with Human Immunodeficiency Virus receiving highly active antiretroviral therapy. Clin Infect Dis. 2002 Jul 01; 35(1):E8-E13. Aberg JA, Chin-Hong PV, McCutchan A, Koletar SL, Currier JS. PMID: 12060894.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    204. Association of adherence to Mycobacterium avium complex prophylaxis and antiretroviral therapy with clinical outcomes in Acquired Immunodeficiency Syndrome. Clin Infect Dis. 2002 Apr 15; 34(8):1129-36. Cohn SE, Kammann E, Williams P, Currier JS, Chesney MA. PMID: 11915003.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    205. Identifying and managing morphologic complications of HIV and HAART. AIDS Read. 2002 Mar; 12(3):114-9, 124-5. Currier J, Carpenter C, Daar E, Kotler D, Wanke C. PMID: 11966241.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    206. Management of metabolic complications of therapy. AIDS. 2002; 16 Suppl 4:S171-6. Currier J. PMID: 12699014.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    207. Metabolic complications of HIV infection: translating research findings into clinical practice. AIDS Clin Care. 2002 Jan; 14(1):1-2, 8. Currier J. PMID: 11802627.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    208. Impact of prophylaxis for Mycobacterium avium complex on bacterial infections in patients with advanced human immunodeficiency virus disease. Clin Infect Dis. 2001 Jun 01; 32(11):1615-22. Currier JS, Williams P, Feinberg J, Becker S, Owens S, Fichtenbaum C, Benson C. PMID: 11340534.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsCTClinical Trials
    209. Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team. Ann Intern Med. 2000 Oct 03; 133(7):493-503. Currier JS, Williams PL, Koletar SL, Cohn SE, Murphy RL, Heald AE, Hafner R, Bassily EL, Lederman HM, Knirsch C, Benson CA, Valdez H, Aberg JA, McCutchan JA. PMID: 11015162.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCellsCTClinical Trials
    210. Differences between women and men in adverse events and CD4+ responses to nucleoside analogue therapy for HIV infection. The Aids Clinical Trials Group 175 Team. J Acquir Immune Defic Syndr. 2000 Aug 01; 24(4):316-24. Currier JS, Spino C, Grimes J, Wofsy CB, Katzenstein DA, Hughes MD, Hammer SM, Cotton DJ. PMID: 11015147.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    211. Discontinuing prophylaxis for opportunistic infection: guiding principles. Clin Infect Dis. 2000 Apr; 30 Suppl 1:S66-71. Currier JS. PMID: 10770914.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    Judith's Networks
    Concepts (530)
    Derived automatically from this person's publications.
    _
    Co-Authors (57)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _